Samin Darou Iranian Company (Joint Stock) was registered in December of 2014 and after equipping the factory with facilities and equipment and creating the necessary spaces for the production of Active Pharmaceutical Ingredients in accordance with GMP principles, it was put into operation in October of 2018.
The factory of this company was built on a land area of 7000 square meters and with an infrastructure of 3400 square meters constructions in Kaveh Industrial City and is equipped with a production hall, clean rooms, Quality Assurance unit, Quality Control, Research & Development, technical and engineering unit and warehouse in accordance with the requirements of the production of Active Pharmaceutical Ingredients which is managed and operated by the company’s experts and experienced personnel.
One of the important advantages of Samin Darou Iranian Company is its R&D through creation of technical know-how to produce new products by the company’s own experts and in accordance with the available facilities in the country. Therefore, the company does not depend on any foreign country in terms of technical know-how to produce and optimize its products, and up to now, the company has been able to produce 17 Active Pharmaceutical Ingredients including: 1) Metformin hydrochloride 2) Azithromycin 3) Thiamine hydrochloride 4) Pantoprazole Sodium 5) Clarithromycin 6) Celecoxib 7) Methocarbamol 8) Losartan 9) Gabapentin 10) Fexofenadine 11) Biperiden hydrochloride 12) Atorvastatin 13) Hydroxychloroquine 14) Niacin 15) Famotidine 16) Acyclovir 17) Venlafaxine with the best methods and the highest quality and sell them to some of the large and famous pharmaceutical companies in Iran.
In the second half of 2019, the design and construction of a pellet products unit at began Samin Daru factory and was put into operation in the second half of 2014. This unit currently has the technical knowledge and formulations to produce 5 pharmaceutical products including: 1) Tamsulosin 0.2%, 2) Pantoprazole Sodium 15%, 3) Diclofenac Sodium 45%, 4) Esomeprazole Magnesium 22.5%, 5) Omeprazole 8.5% and has joined the group of pellet product manufacturers.
